Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited - machinery and equipment in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U29297MH2021PTC355920 Incorporated 25 February 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company machinery and equipment
Data last updated
Revenue · FY 2025
₹6.79 Cr
▲ 84% YoY
Net profit · FY 2025
₹26.59 Lakh
Net margin 3.9%
EBITDA · FY 2025
₹65.76 Lakh
EBITDA margin 9.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Rotek Pharma Technologies Private Limited

Data last updated:

Rotek Pharma Technologies Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the process machinery and industrial equipment segment of the machinery and industrial equipment sector. It was incorporated on 25 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U29297MH2021PTC355920. Its GSTIN is 27AAKCR8240A1ZH (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riddhi Bhupat Palan and Anand Vijay Bhayani.

Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 256 Shanti Ind Estate S N Road Mulund West, Mumbai, Maharashtra, India – 400080.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.79 Cr, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹26.59 Lakh (net margin 3.9%) and EBITDA of ₹65.76 Lakh (EBITDA margin 9.7%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years.

For more details, the company can be reached via its website rotekindia.com.

Company Details of Rotek Pharma Technologies Private Limited
CIN U29297MH2021PTC355920
Registration Number 355920
Incorporation Date 25 February 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    256 Shanti Ind Estate S N Road Mulund West, Mumbai, Maharashtra, India – 400080
  • Industry
    Machinery and Equipment, Process Machinery & Industrial Equipment
Comprehensive company report
Rotek Pharma Technologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Rotek Pharma Technologies Private Limited report

Financials, compliance, directors, charges, ownership and filings for Rotek Pharma Technologies Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Rotek Pharma Technologies Private Limited

The main business activity of Rotek Pharma Technologies is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Rotek Pharma Technologies Private Limited FY 2025 filings available

Rotek Pharma Technologies Private Limited reported revenue of ₹6.79 Cr (up 84% YoY) for FY 2025.

Revenue · FY 2025
₹6.79 Cr ▲ 84%
Net profit · FY 2025
₹26.59 Lakh margin 3.9%
EBITDA · FY 2025
₹65.76 Lakh margin 9.7%

Compounded Annual Growth Rate (CAGR) of Rotek Pharma Technologies Private Limited

Revenue CAGR growth
1 year
▲ 84%
3 years · compounded
▲ 58%
EBITDA CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 101%

Revenue has grown at a compounded annual rate (CAGR) of 58% over three years, including 84% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Rotek Pharma Technologies Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹65.76 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹26.59 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Rotek Pharma Technologies Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.7%••••••••••••••••
Net Profit Margin3.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rotek Pharma Technologies are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited is compared with the companies closest to it by revenue in the Machinery and Equipment industry (Process Machinery). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Raas Technology India Private Limited₹6.82 Cr (FY 2024)••••••••-7.0%••••Ballabgarh, Haryana, India
Kakarla Moulds and Dies Private Limited₹6.82 Cr (FY 2025)••••••••8.0%••••Chennai, Tamil Nadu, India
Avinya Machinery International Private Limited₹6.81 Cr (FY 2025)••••••••262.0%••••Ahmedabad, Gujarat, India
Dudhat Chemequip Private Limited₹6.79 Cr (FY 2025)••••••••-11.0%••••Ahmedabad, Gujarat, India
Sutantra Machines Private Limited₹6.79 Cr (FY 2025)••••••••-15.0%••••Navi Mumbai, Maharashtra, India
Rotek Pharma Technologies Private Limited this company₹6.79 Cr (FY 2025)••••••••84.0%••••Mumbai, Maharashtra, India
Woxn Packaging Solution Private Limited₹6.78 Cr (FY 2025)••••••••350.0%••••Ghaziabad, Uttar Pradesh, India
VK Industries Private Limited₹6.77 Cr (FY 2025)••••••••22.0%••••New Delhi, Delhi, India
Weldor Appliances Private Limited₹6.77 Cr (FY 2025)••••••••5.0%••••Kotda Sanghani, Gujarat, India
Concise Industries Private Limited₹6.74 Cr (FY 2025)••••••••21.0%••••Tijara, Rajasthan, India
Global Water Projects Private Limited₹6.74 Cr (FY 2025)••••••••33.0%••••Chennai, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Rotek Pharma Technologies by revenue in the Machinery and Equipment industry (Process Machinery), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited is audited by LODAYA & CO for the financial year 2021.

NameStatusAppointment DateCessation Date
LODAYA & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Riddhi Bhupat PalanDirector25 Feb 20215 Years 7 MonthsCurrent
Anand Vijay BhayaniDirector25 Feb 20215 Years 7 MonthsCurrent

Ownership and Shareholding of Rotek Pharma Technologies Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited has a workforce of 0 employees as of Apr 05, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anand Vijay Bhayani was appointed as Director on 25 Feb 2021.

AGM
Rotek Pharma Technologies Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Rotek Pharma Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Anand Vijay Bhayani was appointed as Director.
Appointed
Riddhi Bhupat Palan was appointed as Director.
Incorporation
25 Feb 2021
Rotek Pharma Technologies Private Limited was registered on 25 Feb 2021 with Roc Mumbai I & aged 5 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Rotek Pharma Technologies Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Rotek Pharma Technologies Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Rotek Pharma Technologies Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAKCR8240A1ZHMaharashtraActive28 Mar 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Rotek Pharma Technologies Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rotek Pharma Technologies Private Limited

Rotek Pharma Technologies is an active private limited company based in Mumbai, Maharashtra, India. The company works in process machinery and industrial equipment, within the machinery and equipment industry. It was incorporated on 25 February 2021 (5+ years old) and is registered under CIN U29297MH2021PTC355920.

Rotek Pharma Technologies reported revenue of ₹6.79 Cr for FY 2025 (up 84% YoY).

Rotek Pharma Technologies has 2 current directors:

Rotek Pharma Technologies reported a net profit of ₹26.59 Lakh (net margin 3.9%) and EBITDA of ₹65.76 Lakh (EBITDA margin 9.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Rotek Pharma Technologies is 58% over three years. In the latest year (FY 2025) revenue rose 84%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Rotek Pharma Technologies is 27AAKCR8240A1ZH, registered in Maharashtra.

The CIN (Corporate Identification Number) of Rotek Pharma Technologies is U29297MH2021PTC355920. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rotek Pharma Technologies was incorporated on 25 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Rotek Pharma Technologies by revenue are Raas Technology India Private Limited, Kakarla Moulds and Dies Private Limited, Avinya Machinery International Private Limited, Dudhat Chemequip Private Limited, Sutantra Machines Private Limited and 5 more, all in the Machinery and Equipment industry (Process Machinery).

Anand Vijay Bhayani was appointed as Director on 25 Feb 2021. Riddhi Bhupat Palan was appointed as Director on 25 Feb 2021.

Rotek Pharma Technologies can be reached through the website rotekindia.com. Its registered office is in Mumbai, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available